Shield Therapeutics (STX) Stock Chart & Stock Price History GBX 2.85 -0.10 (-3.39%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Shield Therapeutics Stock Price Performance 5 Day Performance-1.72%1 Month Performance-27.85%3 Month Performance-25.00%6 Month Performance+14.18%Year-To-Date Performance-57.46%1 Year Performance-51.69% Receive STX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 9 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now STX Stock Chart for Sunday, November, 24, 2024 STX Chart by TradingView Shield Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024GBX 2.95GBX 2.85-3.39%GBX 2.99GBX 2.832.34 million shs£22.29 million11/21/2024GBX 2.66GBX 2.95+11.11%GBX 3.41GBX 2.8040.62 million shs£23.07 million11/20/2024GBX 2.90GBX 2.66-8.45%GBX 3.08GBX 2.609.18 million shs£20.76 million11/19/2024GBX 2.70GBX 2.90+7.41%GBX 2.99GBX 2.793.91 million shs£22.68 million11/18/2024GBX 2.70GBX 2.70GBX 2.80GBX 2.60366,779 shs£21.12 million11/15/2024GBX 2.63GBX 2.70+2.86%GBX 2.70GBX 2.63339,445 shs£21.12 million Get the Latest News and Ratings for STX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024GBX 2.65GBX 2.63-0.94%GBX 2.70GBX 2.60593,781 shs£20.53 million11/13/2024GBX 2.60GBX 2.65+1.92%GBX 2.65GBX 2.60243,887 shs£20.73 million11/12/2024GBX 2.73GBX 2.60-4.76%GBX 2.70GBX 2.571.39 million shs£20.33 million11/11/2024GBX 2.75GBX 2.73-0.73%GBX 2.80GBX 2.611.77 million shs£21.35 million11/08/2024GBX 2.77GBX 2.77-0.22%GBX 2.80GBX 2.70640,215 shs£21.64 million11/07/2024GBX 2.73GBX 2.77+1.58%GBX 2.78GBX 2.71126,181 shs£21.69 million11/06/2024GBX 2.70GBX 2.73+1.11%GBX 2.80GBX 2.701.32 million shs£21.35 million11/05/2024GBX 2.71GBX 2.70-0.44%GBX 2.80GBX 2.641.54 million shs£21.12 million11/04/2024GBX 3GBX 2.71-9.60%GBX 2.90GBX 2.701.49 million shs£21.21 million11/01/2024GBX 2.98GBX 2.98GBX 3.10GBX 2.90949,623 shs£23.31 million10/31/2024GBX 2.99GBX 2.98-0.17%GBX 3.10GBX 2.806.12 million shs£23.31 million10/30/2024GBX 3.41GBX 2.99-12.46%GBX 3.50GBX 2.826.85 million shs£23.34 million10/29/2024GBX 3.71GBX 3.41-8.09%GBX 3.41GBX 3.2015.18 million shs£26.67 million10/28/2024GBX 4GBX 3.71-7.25%GBX 4GBX 3.703.30 million shs£29.01 million10/25/2024GBX 3.95GBX 3.90-1.27%GBX 4.08GBX 3.901.31 million shs£30.50 million10/24/2024GBX 4.05GBX 3.95-2.47%GBX 4.16GBX 3.804.47 million shs£30.89 million10/23/2024GBX 4.56GBX 4.05-11.22%GBX 4.55GBX 44.12 million shs£31.67 million Related Companies DGI Stock Chart STK Stock Chart EAH Stock Chart PXS Stock Chart CHLL Stock Chart CEL Stock Chart RGT Stock Chart N4P Stock Chart HELD Stock Chart HLN Stock Chart Receive STX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:STX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shield Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Shield Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STX Stock Alerts